Cobalis
Irvine
About Cobalis
Cobalis Corp. is a specialty pharmaceutical development company specializing in medications to prevent and treat atopic disease, including allergies, migraine headache, atopic asthma and dermatitis. Its flagship drug candidate PreHistin is an allergy prevention medication in Phase III clinical development. Cobalis plans to seek FDA approval to market PreHistin over-the-counter in the US.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2007)
- Website: cobalis.com
- Phone: +1 (949)260-9007
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/cobalis-1419529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.